Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 169

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX‐FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family

Open access
Sumegi, Janos, Streblow, Renae, Frayer, Robert W., Cin, Paola Dal, Rosenberg, Andrew, Meloni‐Ehrig, Aurelia, Bridge, Julia A.·2010·Genes, Chromosomes and Cancer

Abstract

The fusion oncoproteins PAX3‐FOXO1 [t(2;13)(q35;q14)] and PAX7‐FOXO1 [t(1;13)(p36;q14)] typify alveolar rhabdomyosarcoma (ARMS); however, 20–30% of cases lack these specific translocations. In this study, cytogenetic and/or molecular characterization to include FISH, reverse transcription polymerase chain reaction (RT‐PCR), and sequencing analyses of five rhabdomyosarcomas [four ARMS and one embryonal rhabdomyosarcoma (ERMS)] with novel, recurrent t(2;2)(p23;q35) or t(2;8)(q35;q13) revealed that these noncanonical translocations fuse PAX3 to NCOA1 or NCOA2, respectively. The PAX3‐NCOA1 and PAX3‐NCOA2 transcripts encode chimeric proteins composed of the paired‐box and homeodomain DNA‐binding domains of PAX3, and the CID domain, the Q‐rich region, and the activation domain 2 (AD2) domain of NCOA1 or NCOA2. To investigate the biological function of these recurrent variant translocations, the coding regions of PAX3‐NCOA1 and PAX3‐NCOA2 cDNA constructs were introduced into expression vectors with tetracycline‐regulated expression. Both fusion proteins showed transforming activity in the soft‐agar assay. Deletion of the AD2 portion of the PAX3‐NCOA fusion proteins reduced the transforming activity of each chimeric protein. Similarly, but with greater impact, CID domain deletion fully abrogated the transforming activity of the chimeric protein. These studies (1) expand our knowledge of PAX3 variant translocations in RMS with identification of a novel PAX3‐NCOA2 fusion, (2) show that both PAX3‐NCOA1 and PAX3‐NCOA2 represent recurrent RMS rearrangements, (3) confirm the transforming activity of both translocation events and demonstrate the essentiality of intact AD2 and CID domains for optimal transforming activity, and (4) provide alternative approaches (FISH and RT‐PCR) for detecting PAX‐NCOA fusions in nondividing cells of RMS. The latter could potentially be used as aids in diagnostically challenging cases. © 2009 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/gcc.20731

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 169

Metadata

Authors
Sumegi, J., Streblow, R., Frayer, R. W., Cin, P. D., Rosenberg, A., Meloni‐Ehrig, A., & Bridge, J. A.
Venue
Genes, Chromosomes and Cancer
Publisher
Wiley
Published
2009-12
Volume
49
Issue
3
Pages
224-236
ISSN
  • 1045-2257 (ISSN-L)
  • 1098-2264
OpenAlex
W2076609303
Cited by
169
References
1
FWCI
8.39
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX‐FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family. https://app.cochat.ai/papers/10.1002/gcc.20731
The paper
Sumegi, J., Streblow, R., Frayer, R. W., Cin, P. D., Rosenberg, A., Meloni‐Ehrig, A., & Bridge, J. A. (2010). Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX‐FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.20731

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.